4
Changes in Ownership
Larimar Therapeutics, Inc. Filed Acc 0001062993-25-001080
Chief Development Officer acquired 23,306 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Shankar Gopi · Chief Development Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-22 | Grant or award : show line 1 in the form | +23,306 | 50,806 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-22 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +139,838 | 139,838 | D |
Loading xslF345X05/form4.xml…